BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Huang GW, Tao YM, Ding X. Endocan expression correlated with poor survival in human hepatocellular carcinoma. Dig Dis Sci. 2009;54:389-394. [PMID: 18592377 DOI: 10.1007/s10620-008-0346-3] [Cited by in Crossref: 50] [Cited by in F6Publishing: 58] [Article Influence: 3.6] [Reference Citation Analysis]
Number Citing Articles
1 Sarrazin S, Lyon M, Deakin JA, Guerrini M, Lassalle P, Delehedde M, Lortat-jacob H. Characterization and binding activity of the chondroitin/dermatan sulfate chain from Endocan, a soluble endothelial proteoglycan. Glycobiology 2010;20:1380-8. [DOI: 10.1093/glycob/cwq100] [Cited by in Crossref: 37] [Cited by in F6Publishing: 29] [Article Influence: 3.1] [Reference Citation Analysis]
2 Hentschke MR, Lucas LS, Mistry HD, Pinheiro da Costa BE, Poli-de-figueiredo CE. Endocan-1 concentrations in maternal and fetal plasma and placentae in pre-eclampsia in the third trimester of pregnancy. Cytokine 2015;74:152-6. [DOI: 10.1016/j.cyto.2015.04.013] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
3 Huang X, Chen C, Wang X, Zhang JY, Ren BH, Ma DW, Xia L, Xu XY, Xu L. Prognostic value of endocan expression in cancers: evidence from meta-analysis. Onco Targets Ther 2016;9:6297-304. [PMID: 27785077 DOI: 10.2147/OTT.S110295] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
4 Yassine H, De Freitas Caires N, Depontieu F, Scherpereel A, Awad A, Tsicopoulos A, Leboeuf C, Janin A, Duez C, Grigoriu B, Lassalle P. The non glycanated endocan polypeptide slows tumor growth by inducing stromal inflammatory reaction. Oncotarget 2015;6:2725-35. [PMID: 25575808 DOI: 10.18632/oncotarget.2614] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
5 Rocha SF, Schiller M, Jing D, Li H, Butz S, Vestweber D, Biljes D, Drexler HC, Nieminen-kelhä M, Vajkoczy P, Adams S, Benedito R, Adams RH. Esm1 Modulates Endothelial Tip Cell Behavior and Vascular Permeability by Enhancing VEGF Bioavailability. Circ Res 2014;115:581-90. [DOI: 10.1161/circresaha.115.304718] [Cited by in Crossref: 86] [Cited by in F6Publishing: 51] [Article Influence: 10.8] [Reference Citation Analysis]
6 Zhao L, Dai C, Gong Q. Changes of Endocan and its effect on hepatic stem cells during the rapid proliferation process of residual liver after ALPPS procedure. Cell Biochem Funct 2020;38:817-25. [PMID: 32515027 DOI: 10.1002/cbf.3553] [Reference Citation Analysis]
7 Palmiere C, Augsburger M. Markers for sepsis diagnosis in the forensic setting: state of the art. Croat Med J 2014;55:103-14. [PMID: 24778096 DOI: 10.3325/cmj.2014.55.103] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
8 Palmiere C, Augsburger M. Endocan measurement for the postmortem diagnosis of sepsis. Legal Medicine 2014;16:1-7. [DOI: 10.1016/j.legalmed.2013.09.007] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
9 Yang WE, Hsieh MJ, Lin CW, Kuo CY, Yang SF, Chuang CY, Chen MK. Plasma Levels of Endothelial Cell-Specific Molecule-1 as a Potential Biomarker of Oral Cancer Progression. Int J Med Sci 2017;14:1094-100. [PMID: 29104463 DOI: 10.7150/ijms.20414] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
10 Toshikuni N, Ozaki K, George J, Tsutsumi M. Serum endocan as a survival predictor for patients with liver cirrhosis. Can J Gastroenterol Hepatol 2015;29:427-30. [PMID: 26669300 DOI: 10.1155/2015/153805] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
11 Wang S, Wu Z, Wei L, Zhang J. Endothelial cell-specific molecule-1 as an invasiveness marker for pituitary null cell adenoma. BMC Endocr Disord 2019;19:90. [PMID: 31455321 DOI: 10.1186/s12902-019-0418-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
12 Kul A, Ateş O, Alkan Melikoğlu M, Uğur M, Öztürk N, Erkayhan G, Koçer İ. Endocan Measurement for Active Behçet Disease. Arch Rheumatol 2017;32:197-202. [PMID: 30375545 DOI: 10.5606/ArchRheumatol.2017.6072] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Kang YH, Ji NY, Han SR, Lee CI, Kim JW, Yeom YI, Kim YH, Chun HK, Kim JW, Chung JW, Ahn DK, Lee HG, Song EY. ESM-1 regulates cell growth and metastatic process through activation of NF-κB in colorectal cancer. Cellular Signalling 2012;24:1940-9. [DOI: 10.1016/j.cellsig.2012.06.004] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 4.1] [Reference Citation Analysis]
14 Chang Y, Niu W, Lian PL, Wang XQ, Meng ZX, Liu Y, Zhao R. Endocan-expressing microvessel density as a prognostic factor for survival in human gastric cancer. World J Gastroenterol 2016; 22(23): 5422-5429 [PMID: 27340359 DOI: 10.3748/wjg.v22.i23.5422] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.7] [Reference Citation Analysis]
15 Leroy X, Aubert S, Zini L, Franquet H, Kervoaze G, Villers A, Delehedde M, Copin MC, Lassalle P. Vascular endocan (ESM-1) is markedly overexpressed in clear cell renal cell carcinoma. Histopathology. 2010;56:180-187. [PMID: 20102396 DOI: 10.1111/j.1365-2559.2009.03458.x] [Cited by in Crossref: 75] [Cited by in F6Publishing: 78] [Article Influence: 6.3] [Reference Citation Analysis]
16 Zhang S, Zuo L, Zhou Q, Gui S, Shi R, Wu Q, Wei W, Wang Y. Expression and distribution of endocan in human tissues. Biotechnic & Histochemistry 2012;87:172-8. [DOI: 10.3109/10520295.2011.577754] [Cited by in Crossref: 58] [Cited by in F6Publishing: 62] [Article Influence: 5.3] [Reference Citation Analysis]
17 Chen LY, Liu X, Wang SL, Qin CY. Over-expression of the Endocan gene in endothelial cells from hepatocellular carcinoma is associated with angiogenesis and tumour invasion. J Int Med Res. 2010;38:498-510. [PMID: 20515564 DOI: 10.1177/147323001003800213] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 4.1] [Reference Citation Analysis]
18 Zhou F, Hu J, Shao JH, Zou SB, Shen SL, Luo ZQ. Metronomic chemotherapy in combination with antiangiogenic treatment induces mosaic vascular reduction and tumor growth inhibition in hepatocellular carcinoma xenografts. J Cancer Res Clin Oncol 2012;138:1879-90. [PMID: 22736027 DOI: 10.1007/s00432-012-1270-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
19 Zhang Q, Wu J, Bai X, Liang T. Evaluation of Intra-Tumoral Vascularization in Hepatocellular Carcinomas. Front Med (Lausanne). 2020;7:584250. [PMID: 33195338 DOI: 10.3389/fmed.2020.584250] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Ji NY, Kim YH, Jang YJ, Kang YH, Lee CI, Kim JW, Yeom YI, Chun HK, Choi YH, Kim JH, Kim JW, Lee HG, Song EY. Identification of endothelial cell-specific molecule-1 as a potential serum marker for colorectal cancer. Cancer Sci 2010;101:2248-53. [PMID: 20735430 DOI: 10.1111/j.1349-7006.2010.01665.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 2.2] [Reference Citation Analysis]
21 Zhang S, Zuo L, Gui S, Zhou Q, Wei W, Wang Y. Induction of cell differentiation and promotion of endocan gene expression in stomach cancer by melatonin. Mol Biol Rep 2012;39:2843-9. [PMID: 21678055 DOI: 10.1007/s11033-011-1043-4] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
22 Lee W, Ku S, Kim S, Bae J. Endocan Elicits Severe Vascular Inflammatory Responses In Vitro and In Vivo: ROLE OF ENDOCAN IN SEPSIS LETHALITY. J Cell Physiol 2014;229:620-30. [DOI: 10.1002/jcp.24485] [Cited by in Crossref: 75] [Cited by in F6Publishing: 78] [Article Influence: 9.4] [Reference Citation Analysis]
23 Ozaki K, Toshikuni N, George J, Minato T, Matsue Y, Arisawa T, Tsutsumi M. Serum endocan as a novel prognostic biomarker in patients with hepatocellular carcinoma. J Cancer. 2014;5:221-230. [PMID: 24665346 DOI: 10.7150/jca.7691] [Cited by in Crossref: 30] [Cited by in F6Publishing: 36] [Article Influence: 3.8] [Reference Citation Analysis]
24 Kang YH, Ji NY, Lee CI, Lee HG, Kim JW, Yeom YI, Kim DG, Yoon SK, Kim JW, Park PJ, Song EY. ESM-1 silencing decreased cell survival, migration, and invasion and modulated cell cycle progression in hepatocellular carcinoma. Amino Acids 2011;40:1003-13. [PMID: 20821239 DOI: 10.1007/s00726-010-0729-6] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 2.8] [Reference Citation Analysis]
25 Yu PH, Chou SF, Chen CL, Hung H, Lai CY, Yang PM, Jeng YM, Liaw SF, Kuo HH, Hsu HC, Chen JY, Wang WB. Upregulation of endocan by Epstein-Barr virus latent membrane protein 1 and its clinical significance in nasopharyngeal carcinoma. PLoS One 2013;8:e82254. [PMID: 24340011 DOI: 10.1371/journal.pone.0082254] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
26 Matano F, Yoshida D, Ishii Y, Tahara S, Teramoto A, Morita A. Endocan, a new invasion and angiogenesis marker of pituitary adenomas. J Neurooncol 2014;117:485-91. [DOI: 10.1007/s11060-014-1377-6] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 4.0] [Reference Citation Analysis]
27 Yang J, Sheng S, Yang Q, Li L, Qin S, Yu S, Zhang X. Endocan silencing induces programmed cell death in hepatocarcinoma. Oncol Lett 2017;14:5333-9. [PMID: 29113167 DOI: 10.3892/ol.2017.6857] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
28 Xu L, Tang L, Zhang L. Proteoglycans as miscommunication biomarkers for cancer diagnosis. Glycans and Glycosaminoglycans as Clinical Biomarkers and Therapeutics - Part A. Elsevier; 2019. pp. 59-92. [DOI: 10.1016/bs.pmbts.2018.12.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
29 Irani S, Dehghan A. The Expression and Functional Significance of Vascular Endothelial-Cadherin, CD44, and Vimentin in Oral Squamous Cell Carcinoma. J Int Soc Prev Community Dent 2018;8:110-7. [PMID: 29780735 DOI: 10.4103/jispcd.JISPCD_408_17] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
30 Depontieu F, de Freitas Caires N, Gourcerol D, Giordano J, Grigoriu B, Delehedde M, Lassalle P. Development of monoclonal antibodies and ELISA specific for the mouse vascular endocan. J Immunol Methods 2012;378:88-94. [PMID: 22370430 DOI: 10.1016/j.jim.2012.02.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
31 Huang GW, Ding X, Chen SL, Zeng L. Expression of claudin 10 protein in hepatocellular carcinoma: impact on survival. J Cancer Res Clin Oncol 2011;137:1213-8. [PMID: 21647678 DOI: 10.1007/s00432-011-0987-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
32 Delehedde M, Devenyns L, Maurage CA, Vivès RR. Endocan in cancers: a lesson from a circulating dermatan sulfate proteoglycan. Int J Cell Biol. 2013;2013:705027. [PMID: 23606845 DOI: 10.1155/2013/705027] [Cited by in Crossref: 54] [Cited by in F6Publishing: 59] [Article Influence: 6.0] [Reference Citation Analysis]
33 Zhang H, Shen YW, Zhang LJ, Chen JJ, Bian HT, Gu WJ, Zhang H, Chen HZ, Zhang WD, Luan X. Targeting Endothelial Cell-Specific Molecule 1 Protein in Cancer: A Promising Therapeutic Approach. Front Oncol 2021;11:687120. [PMID: 34109132 DOI: 10.3389/fonc.2021.687120] [Reference Citation Analysis]
34 Atukeren P, Kunbaz A, Turk O, Kemerdere R, Ulu MO, Turkmen Inanir N, Tanriverdi T. Expressions of Endocan in Patients with Meningiomas and Gliomas. Dis Markers 2016;2016:7157039. [PMID: 27528791 DOI: 10.1155/2016/7157039] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
35 Kechagia M, Papassotiriou I, Gourgoulianis KI. Endocan and the respiratory system: a review. Int J Chron Obstruct Pulmon Dis 2016;11:3179-87. [PMID: 28003744 DOI: 10.2147/COPD.S118692] [Cited by in Crossref: 19] [Cited by in F6Publishing: 7] [Article Influence: 3.2] [Reference Citation Analysis]
36 Bettin A, Reyes I, Reyes N. Gene Expression Profiling of Prostate Cancer–Associated Genes Identifies Fibromodulin as Potential Novel Biomarker for Prostate Cancer. Int J Biol Markers 2016;31:153-62. [DOI: 10.5301/jbm.5000184] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
37 Chen CM, Lin CL, Chiou HL, Hsieh SC, Lin CL, Cheng CW, Hung CH, Tsai JP, Hsieh YH. Loss of endothelial cell-specific molecule 1 promotes the tumorigenicity and metastasis of prostate cancer cells through regulation of the TIMP-1/MMP-9 expression. Oncotarget 2017;8:13886-97. [PMID: 28108731 DOI: 10.18632/oncotarget.14684] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
38 Voiosu AM, Bălănescu P, Daha I, Smarandache B, Rădoi A, Mateescu RB, Băicuş CR, Voiosu TA. The diagnostic and prognostic value of serum endocan in patients with cirrhotic cardiomyopathy. Rom J Intern Med 2018;56:182-92. [PMID: 29453929 DOI: 10.2478/rjim-2018-0007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
39 Li Y, Ma X, Zhang J, Liu X, Liu L. Prognostic value of microvessel density in hepatocellular carcinoma patients: a meta-analysis. Int J Biol Markers. 2014;29:e279-e287. [PMID: 24803279 DOI: 10.5301/jbm.5000087] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
40 Ziol M, Sutton A, Calderaro J, Barget N, Aout M, Leroy V, Blanc J, Sturm N, Bioulac-sage P, Nahon P, Nault J, Charnaux N, N’kontchou G, Trinchet J, Delehedde M, Seror O, Beaugrand M, Vicaut E, Ganne-carrié N. ESM-1 expression in stromal cells is predictive of recurrence after radiofrequency ablation in early hepatocellular carcinoma. Journal of Hepatology 2013;59:1264-70. [DOI: 10.1016/j.jhep.2013.07.030] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 2.7] [Reference Citation Analysis]
41 Wahb AMSE, El Kassas M, Khamis AK, Elhelbawy M, Elhelbawy N, Habieb MSE. Circulating microRNA 9-3p and serum endocan as potential biomarkers for hepatitis C virus-related hepatocellular carcinoma. World J Hepatol 2021; 13(11): 1753-1765 [PMID: 34904043 DOI: 10.4254/wjh.v13.i11.1753] [Reference Citation Analysis]
42 Baghy K, Tátrai P, Regős E, Kovalszky I. Proteoglycans in liver cancer. World J Gastroenterol 2016; 22(1): 379-393 [PMID: 26755884 DOI: 10.3748/wjg.v22.i1.379] [Cited by in CrossRef: 49] [Cited by in F6Publishing: 50] [Article Influence: 8.2] [Reference Citation Analysis]
43 Pan WD, Zheng RQ, Nan L, Fang HP, Liu B, Tang ZF, Deng MH, Xu RY. Ultrasound-guided percutaneous microwave coagulation therapy with a “cooled-tip needle” for the treatment of hepatocellular carcinoma adjacent to the gallbladder. Dig Dis Sci. 2010;55:2664-2669. [PMID: 19949862 DOI: 10.1007/s10620-009-1053-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
44 Sagara A, Igarashi K, Otsuka M, Kodama A, Yamashita M, Sugiura R, Karasawa T, Arakawa K, Narita M, Kuzumaki N, Narita M, Kato Y. Endocan as a prognostic biomarker of triple-negative breast cancer. Breast Cancer Res Treat 2017;161:269-78. [PMID: 27888420 DOI: 10.1007/s10549-016-4057-8] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.7] [Reference Citation Analysis]
45 Lin LY, Yeh YC, Chu CH, Won JGS, Shyr YM, Chao Y, Li CP, Wang SE, Chen MH. Endocan expression is correlated with poor progression-free survival in patients with pancreatic neuroendocrine tumors. Medicine (Baltimore) 2017;96:e8262. [PMID: 29019897 DOI: 10.1097/MD.0000000000008262] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]
46 Lai CY, Chen CM, Hsu WH, Hsieh YH, Liu CJ. Overexpression of Endothelial Cell-Specific Molecule 1 Correlates with Gleason Score and Expression of Androgen Receptor in Prostate Carcinoma. Int J Med Sci 2017;14:1263-7. [PMID: 29104483 DOI: 10.7150/ijms.21023] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
47 Celik ZE, Demir F, Yonar H, Ugras S. Association of endocan expression with clinicopathological prognostic parameters in breast carcinoma. Cancer Biomark 2021. [PMID: 34151832 DOI: 10.3233/CBM-201026] [Reference Citation Analysis]
48 Li C, Geng H, Ji L, Ma X, Yin Q, Xiong H. ESM-1: A Novel Tumor Biomaker and its Research Advances. ACAMC 2019;19:1687-94. [DOI: 10.2174/1871520619666190705151542] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
49 Cai L, Leng ZG, Guo YH, Lin SJ, Wu ZR, Su ZP, Lu JL, Wei LF, Zhuge QC, Jin K, Wu ZB. Dopamine agonist resistance-related endocan promotes angiogenesis and cells viability of prolactinomas. Endocrine 2016;52:641-51. [PMID: 26662185 DOI: 10.1007/s12020-015-0824-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
50 Cornelius A, Cortet-Rudelli C, Assaker R, Kerdraon O, Gevaert MH, Prévot V, Lassalle P, Trouillas J, Delehedde M, Maurage CA. Endothelial expression of endocan is strongly associated with tumor progression in pituitary adenoma. Brain Pathol. 2012;22:757-764. [PMID: 22353248 DOI: 10.1111/j.1750-3639.2012.00578.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 4.4] [Reference Citation Analysis]
51 Paulus P, Jennewein C, Zacharowski K. Biomarkers of endothelial dysfunction: can they help us deciphering systemic inflammation and sepsis? Biomarkers 2011;16 Suppl 1:S11-21. [PMID: 21707440 DOI: 10.3109/1354750X.2011.587893] [Cited by in Crossref: 110] [Cited by in F6Publishing: 60] [Article Influence: 10.0] [Reference Citation Analysis]
52 Faruk Ozdemir A, Kemerdere R, Orhan B, Ozturk Emre H, Bercik Inal B, Kayhan A, Naz Yeni S, Tanriverdi T. Serum endocan and preoperative systemic inflammatory markers in patients with epilepsy. Neurochirurgie 2020;66:29-35. [DOI: 10.1016/j.neuchi.2019.09.025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
53 Kali A, Shetty KS. Endocan: a novel circulating proteoglycan. Indian J Pharmacol 2014;46:579-83. [PMID: 25538326 DOI: 10.4103/0253-7613.144891] [Cited by in Crossref: 61] [Cited by in F6Publishing: 55] [Article Influence: 8.7] [Reference Citation Analysis]
54 Pan KF, Yang YC, Lee WJ, Hua KT, Chien MH. Proteoglycan Endocan: A multifaceted therapeutic target in Cancer. Biochim Biophys Acta Rev Cancer 2021;1877:188672. [PMID: 34953930 DOI: 10.1016/j.bbcan.2021.188672] [Reference Citation Analysis]
55 Lv Z, Fan Y, Chen H, Zhao D. Endothelial cell-specific molecule-1: a potential serum marker for gastric cancer. Tumour Biol 2014;35:10497-502. [PMID: 25056533 DOI: 10.1007/s13277-014-2319-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
56 Maurage CA, Adam E, Minéo JF, Sarrazin S, Debunne M, Siminski RM, Baroncini M, Lassalle P, Blond S, Delehedde M. Endocan expression and localization in human glioblastomas. J Neuropathol Exp Neurol 2009;68:633-41. [PMID: 19458546 DOI: 10.1097/NEN.0b013e3181a52a7f] [Cited by in Crossref: 70] [Cited by in F6Publishing: 41] [Article Influence: 5.4] [Reference Citation Analysis]
57 Wang Z, Li J, Ji Y, An P, Zhang S, Li Z. Traditional herbal medicine: a review of potential of inhibitory hepatocellular carcinoma in basic research and clinical trial. Evid Based Complement Alternat Med 2013;2013:268963. [PMID: 23956767 DOI: 10.1155/2013/268963] [Cited by in Crossref: 14] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
58 Zhao W, Sun M, Li S, Wang Y, Liu J. Biological and clinical implications of endocan in gastric cancer. Tumour Biol 2014;35:10043-9. [PMID: 25012244 DOI: 10.1007/s13277-014-2287-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
59 Bălănescu P, Lădaru A, Bălănescu E, Voiosu T, Băicuş C, Dan GA. Endocan, Novel Potential Biomarker for Systemic Sclerosis: Results of a Pilot Study. J Clin Lab Anal 2016;30:368-73. [PMID: 26331941 DOI: 10.1002/jcla.21864] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]